Navigation Links
Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
Date:9/25/2007

tient care by combining the latest medical device innovations with world-class pharmaceuticals, investing in research and development, and advancing medicine through training and education. Headquartered in Northern California, Abbott Vascular offers a comprehensive portfolio of vessel closure, endovascular and coronary products that are recognized internationally for their safety and effectiveness in treating patients with vascular disease.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.


'/>"/>
SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
8. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
9. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
10. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
11. Malvern initiates European user group meetings for chemical imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... ALEXANDRIA, Va. , May 20, 2013   ... B. Douglas Hoey , RPh, MBA issued the ... Hart Research Associates regarding Medicare Part D "preferred ... pharmacies from offering patients the plan,s lowest advertised co-payments: ... "Officials with Medicare and MedPAC , ...
(Date:5/20/2013)... MAPLE GROVE, Minn. , May 20, 2013 ... committed to the development of new treatments for ... the launch of its newly designed website, ... through images and narratives.  As part of the ... – our new branding campaign centers around people ...
(Date:5/20/2013)... 20, 2013 /PRNewswire-iReach/ -- Today at American Society ... Christine Ginocchio discussed Specific Technologies blood ... identification of microorganisms producing bloodstream infection. Dr. Ginocchio ... the Division of Infectious Disease Diagnostics at North ... non-sectarian health system. (Photo: http://photos.prnewswire.com/prnh/20130520/CG16829 ...
Breaking Medicine Technology:Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4Upsher-Smith Introduces Newly Redesigned Corporate Website 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3
... 8, 2012 /PRNewswire-Asia / -- WuXi PharmaTech (Cayman) Inc. ... and medical device R&D outsourcing company with operations in ... will release financial results for the fourth quarter of ... Thursday, March 8, 2012 (which will be Friday morning, ...
... SACRAMENTO, Calif., Feb. 7, 2012 Sutter Medical Center, ... nation and the first in California to receive full ... Centers (SCPC). The announcement comes as the nation ushers in ... is the most common cardiac arrhythmia that can lead ...
Cached Medicine Technology:WuXi PharmaTech Schedules Fourth-Quarter 2011 Earnings Release 2Sutter Medical Center First in California to Receive Atrial Fibrillation Certification 2
(Date:5/20/2013)... 2013) - A new "telerehabilitation" approach lets physical therapists ... Internet, with good accuracy compared with face-to-face examinations, reports ... Spine . The journal is published ... of Wolters Kluwer Health . , Taking advantage ... a more feasible alternative to in-person clinic visits, according ...
(Date:5/20/2013)... May 20, 2013 Medicare Part D ... satisfied, citing lower costs, convenient access to pharmacies and ... Research Associates released today by the Pharmaceutical Care Management ... (9.5 million) are currently enrolled in plans with preferred ... and overall value of plans with preferred pharmacy networks,” ...
(Date:5/20/2013)... 2013 Cliff Lake Dental Care is pleased to ... schedules when visiting the dentist office . The change was ... schedule. , Here are the new office hours: Mondays- 8 a.m. ... 8 a.m. to 1 p.m. and 2-5 p.m., Thursdays 7 a.m. ... will be open to take appointments only. Cliff Lake Dental wants ...
(Date:5/20/2013)... 20, 2013 A pioneer and ... solutions, i2i Systems announced today that ... Foundation (SCF) selected i2iTracks as their population management ... meet their Meaningful Use (MU), Government Performance and ... requirements – a welcomed solution to managing the ...
(Date:5/20/2013)... May 20, 2013 Selexis SA, a ... identification and cell line development for scale-up and manufacturing ... co-founder will present data on the Company’s core technology ... Engineering Conference, May 20 - 23 at the Hyatt ... Selexis’ co-founder and scientific advisory board member, Nicolas Mermod, ...
Breaking Medicine News(10 mins):Health News:Telerehabilitation allows accurate assessment of patients with low back pain 2Health News:Telerehabilitation allows accurate assessment of patients with low back pain 3Health News:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2Health News:Cliff Lake Dental Care Announces Office Hours Change 2Health News:Baldrige Award Winner Southcentral Foundation Selects i2iTracks Population Health Intelligence Solution to Support Meaningful Use, GPRA and UDS Reporting Requirements 2Health News:Baldrige Award Winner Southcentral Foundation Selects i2iTracks Population Health Intelligence Solution to Support Meaningful Use, GPRA and UDS Reporting Requirements 3Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 2Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 3
... new but today there is a growing industry catering to ... National Guard Sgt. Darrell "J.R." Salzman has learned to tie ... shiny metal hook that serves as his right called Utah ... myoelectric Utah Arm, made by Motion Control Inc., of Salt ...
... number of doctors in Portugal were refusing to carry out ... the 10th week of pregnancy . ,The law ... at least nine public hospitals out of a total of ... approved the law in March after a February referendum found ...
... Asbestos Saskatchewan committee, the Canadian Cancer Society's call for a ... is welcomed news and reflects a changing environment. ,"Obviously ... Canada of public interests and social justice organizations to put ... political agenda, Sass was quoted.,"Up to now it has not ...
... will build a 60-acre health and education complex in Islamabad ... people of the capital and the twin city of Rawalpindi ... residential development plan to develop a Health and Education City ... colleges of medicine, nursing, and dentistry. ,Harvard ...
... A new study has found that divorce, not shared genetic ... to the higher rates of break-ups experienced by the offspring ... study to look at genetics as a reason in the ... found that the parents' divorce itself, played a key role ...
... of children ages 5 to 7,C-reactive protein, a marker ... disease, may also indicate cognitive impairment in children ... OSA have increased levels of hsCRP [high-sensitivty C-reactive protein] ... David Gozal, M.D., of the University of Louisville in ...
Cached Medicine News:Health News:War Stimulates Research Blitz in Prosthetics Industry 2Health News:Move To Ban Asbestos Welcomed 2Health News:Genetics is Not the Reason for Family Break-ups 2Health News:C -reactive Protein is the Marker for Cardiovascular Disease 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: